VentriPoint Diagnostics Ltd. (TSXV:VPT) announced a non-brokered private placement of up to 1,000 debenture units at a price of CAD 1,000 per debenture unit for gross proceeds of CAD 1,000,000 on January 9, 2019. Each unit will be comprised of CAD 1,000 principal amount of convertible unsecured debentures which shall mature three years from the date of issuance and 6,000 common share purchase warrants. Each warrant exercisable for one common share at an exercise price of CAD 0.175 per common share for a period of 18 months. The debentures will bear simple interest at an annual rate of 6.5%. The debentures are convertible into common shares at CAD 0.155 per share. The debentures may be redeemed in whole or in part upon payment of the principal amount plus a premium of 2.5% of such principal amount and all accrued and unpaid interest. The company may pay registered finders a finder's fee of up to 7% of the gross proceeds of the transaction and up to 7% warrants. Each finder's warrant will be exercisable into one share at an exercise price of CAD 0.175 per share for a period of 18 months. The transaction is subject to a hold period of four months plus one day from the date of closing. The transaction is subject to approval of TSX Venture Exchange.